Wild M&A rumors spread

Korean pharmaceutical companies are considering mergers and acquisitions (M&As) in order to make them more productive and profitable, but groundless information on M&A may give adverse effect to firms, critics say.

The domestic pharmaceutical industry lags far behind those of advanced countries, due mainly to heavy regulation and a lack of investment.

For years, the Korean pharmaceutical...